Select agent regulations

Janet C Gonder1

  • 1Garber Consulting LLC, Pinehurst, NC, USA.

ILAR Journal
|January 13, 2005
PubMed

Insights

New regulations govern the use of select agents and toxins in research. Researchers must adapt to new requirements for safety, security, and record-keeping for these biological agents.

Area of Science:

  • Biosecurity
  • Microbiology
  • Public Health Policy

Background:

  • Increased research with biological agents necessitates stringent oversight.
  • Potential misuse of select agents and toxins requires regulatory frameworks.
  • Existing regulations aim to ensure responsible scientific practices.

Purpose of the Study:

  • To provide an overview of recent regulations concerning select agents and toxins.
  • To highlight the challenges researchers face in complying with these regulations.
  • To guide researchers on obtaining further information on relevant standards and guidelines.

Main Methods:

  • Review of current legislation and regulatory policies.
  • Analysis of institutional and investigator adaptation to new requirements.
  • Identification of key compliance challenges: registration, security, safety, and record-keeping.

Main Results:

  • New laws and regulations have been enacted for the use of select agents and toxins.
  • Researchers encounter significant challenges in registration, security, safety, and record-keeping.
  • Adaptation to these regulatory requirements is essential for continuing research.

Conclusions:

  • Compliance with select agent and toxin regulations is critical for legitimate research.
  • Understanding and adhering to these regulations is paramount for institutions and investigators.
  • Resources for navigating these complex guidelines are available to researchers.

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Masking and Demasking Agents01:19

Masking and Demasking Agents

EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...